APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 51 filers reported holding APTEVO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,000 | +12.5% | 27,200 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $16,000 | -33.3% | 27,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $24,000 | 0.0% | 27,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $24,000 | -31.4% | 27,200 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $35,000 | -28.6% | 27,200 | +81.3% | 0.00% | -33.3% |
| Q1 2018 | $49,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,894,219 | $3,505,000 | 2.02% |
| CVI Holdings, LLC | 780,720 | $703,000 | 0.67% |
| Worth Venture Partners, LLC | 429,000 | $387,000 | 0.22% |
| Sessa Capital IM, L.P. | 1,021,836 | $920,000 | 0.13% |
| 683 Capital Management, LLC | 575,000 | $518,000 | 0.05% |
| Park West Asset Management LLC | 1,000,000 | $900,000 | 0.04% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $44,140,000 | 0.02% |
| Point72 Asset Management, L.P. | 2,200,000 | $1,980,000 | 0.01% |
| Alyeska Investment Group, L.P. | 750,000 | $675,000 | 0.01% |
| Alyeska Investment Group, L.P. | 701,655 | $631,000 | 0.01% |